
AttackMS
@attackms_trial
Testing the safety and efficacy of natalizumab (Tysabri) very early in MS. Evidence suggests this will give MS patients a better long-term outcome.
ID: 1666476262112600066
07-06-2023 16:05:01
10 Tweet
129 Followers
219 Following

Diagnosing #MS can be a lengthy procedure, and getting on a treatment path can take even longer. So what happens when you treat potential MS really early? In this episode, we talk to Klaus Schmierer🎗️🇺🇦 & Rachel Horne about the AttackMS trial. Listen now pulse.ly/c9kdvi36e3


Why has the AttackMS trial been suggested to me? Hear from Wendy and Dom theMSguide.com 🧠 about what the trial involves youtu.be/0j-t2qUhhO0

AttackMS is working to show why prompt treatment is needed to help people live well with MS. We're looking for participants with possible MS symptoms in the last 14 days. Get in touch: [email protected]

Please help us spread the word #AttackMS Trial of a highly effective treatment within 14 days of first symptom(s) Contact [email protected] MSTrust MS Society UK Shift.ms MS-UK - Multiple Sclerosis Charity National MS Society


2 new participants enrolled today! 🥳 #AttackMS participants are diagnosed and start treatment within 2 weeks, compared to many months wait with the current NHS pathway. Congratulations to @RoyalLondonHosp Barts Health Chelsea and Westminster Hospital Klaus Schmierer🎗️🇺🇦

Fantastic new tool to help MS patients navigate life during this time of long waits for NHS services, developed by a member of the #AttackMS team Andrea Stennett PhD 👏👏👏 AttackMS participants have fast access to treatment - we hope everyone will one day soon!

📢#AttackMS Recruitment SUSPENDED until further notice. Enrolled participants are safe. Email [email protected] remains open "Don't despair: despair suggests you are in total control and know what's coming. You don't – surrender to events with hope" (Alain de Botton)🤞
